Featured News
Showcasing our technology platforms and scientific advancements
// Mar 12, 2026 | Pharma Manufacturing
ElevateBio BaseCamp Pittsburgh seen as model for US manufacturing
// Feb 27, 2026 | Pittsburgh Business Times
Viewpoint: The U.S. government is betting big on biotech: Is this Pittsburgh’s moment to lead?
// Nov 05, 2025 | Pharma Manufacturing
Well-funded startup ElevateBio looks to attain critical manufacturing mass
With $1.3 billion in funding, the company has established a cGMP manufacturing facility in Waltham, Massachusetts, with a second site under construction in Pittsburgh.
// Oct 07, 2025 | BioSpace
BioSpace Honors 40 Under 40 Winners Whose Impact Reflects Industry’s Grit
The inaugural 40 Under 40 cohort includes CEOs, leaders who have founded or co-founded their company and executives from a range of disciplines. Winners’ accomplishments include shaping drug development, achieving key FDA milestones and launching a new field of study.
// Aug 14, 2025 | BioPharm
ElevateBio BaseCamp Achieves First Multi-Modality ICMC Certification in Commercial CGT Manufacturing
ElevateBio's BaseCamp facility achieved ICMC certification for multi-modal manufacturing capabilities, marking a first in genetic medicines manufacturing.
// Jun 12, 2025 | CNBC
CNBC Disruptor 50: ElevateBio CEO Ger Brophy on AI and CRISPR for rare disease treatments
ElevateBio CEO Ger Brophy joins ‘Worldwide Exchange’ as ElevateBio ranks #43 on the Disruptor 50 list.
// Mar 11, 2025 | Drug Target Review
AWS and ElevateBio join forces to advance gene editing
ElevateBio is teaming up with Amazon Web Services (AWS) to advance CRISPR gene editing using AI and cloud computing. This collaboration aims to accelerate drug discovery for genetic diseases, making next-generation therapies more efficient and accessible.
// May 23, 2024 | Cell and Gene Therapy
Outsourced Pharma Capacity Update May 2024
Debaditya Bhattacharya, Ph.D. VP, Analytical Development and Miranda Williams Scientist I, Analytical Development discuss BaseCamp’s analytical capabilities and more in a recorded webcast.
// May 14, 2024 | CNBC
ElevateBio CEO on disruptive potential for gene and cell therapies
David Hallal, ElevateBio CEO, joins ‘Fast Money’ to talk making CNBC’s Disruptor 50 list, what is included in its portfolio, innovation in cell and gene therapy and more.
// May 24, 2023 | Fierce Biotech
ElevateBio takes fundraising crown with $401M series D, adds Novo Nordisk to growing army of partners
Move over, ReNAgade Therapeutics. After just one day, ElevateBio’s $401 million haul has already bumped the RNA company’s $300 million series A out of the running for the largest private biotech fundraise of 2023.
// Feb 28, 2023 | The Long Run
A Life in Biotech & the Cell Therapy Wave: David Hallal on The Long Run
This episode was recorded in person at the JP Morgan Healthcare Conference in San Francisco. Biotech history buffs will especially enjoy the first half, where he talks about what pharmaceutical sales was like and what it was like to work at Amgen in the early days.
// Oct 12, 2022 | Biotech 2050 Podcast
A New Vision for Cell and Gene Therapy, Andrew Sandford & Michael Paglia, ElevateBio BaseCamp
Andrew Sandford and Michael Paglia are the President and COO, respectively, of ElevateBio BaseCamp, a cell and gene therapy technology company powering transformative therapies. They join us from the company’s manufacturing facilities in Waltham, Massachusetts, for a discussion about the landscape of company creation in the cell and gene therapy space and how ElevateBio is helping companies bring innovation and therapeutics to clinics and patients to help treat and cure diseases.
